Heart Attack Patient Costs Skyrocket Beyond 30 Days
Likosky says that the research period did not extend beyond 2008, when new payment policies from the Centers for Medicare & Medicaid Services attempted to reign in ambulatory spending for imaging, and benefits for hospice care were limited.
In an accompanying commentary, Ashish Jha, MD, professor of health policy and management at the Harvard School of Public Health, noted that "the additional spending went toward paying for more skilled nursing facilities, physician's visits, home health care, and durable medical equipment. Although readmission rates in the late period remained stable, the spending per readmission went up—with little evidence that patients benefited."
Jha also noted that not only are these post-acute episode services expensive to Medicare "but to the beneficiaries as well," prompting them to incur "substantial out-of-pocket costs."
Likosky's report, Jha wrote, "should be a wake-up call for federal policy makers" to focus on cost reductions beyond 30 days, and is "a timely reminder of the importance of research and data for policy making."
Cheryl Clark is senior quality editor and California correspondent for HealthLeaders Media. She is a member of the Association of Health Care Journalists.
- Drug Pricing 'Tantamount to Greed,' Lawmaker Says
- Study Puts Spotlight on Preventing Fall-Related Injuries
- CVS Ramps Up Retail Clinics with Provider Affiliations
- Surgical Checklists Unused in 10% of Hospitals, CMS Data Shows
- Wanted: Nurse PhDs
- The Infection-Busting Treatment Payers Don’t Want to Talk About
- 4 Tectonic Shifts Shaking Up Healthcare
- Contradictory Obamacare Rulings Issued by Appellate Courts
- As HIPAA Breaches Accelerate, Tools Lag
- Doctors Feel Pressure to Accept Risk-based Reimbursement